Doubts over use of rosuvastatin in HF

A statin fails to prevent cardiovascular death in elderly patients with heart failure, say Swedish scientists.

In a trial presented at the American Heart Association scientific sessions in Orlando, Florida, researchers said they failed to find an improvement in cardiovascular death rates among patients over 60 with systolic or ischaemic heart failure when given rosuvastatin.

In the study, 5,011 patients with moderate to severe heart failure were assigned rosuvastatin 10mg or placebo.

A reduction in cardiovascular events of 16 per cent was expected, said lead researcher Professor Ake Hjalmarson from the Sahlgrenska University Hospital in Goteborg.

A mean follow-up of two years and nine months found the rate of cardiovascular events was lowered by just 8 per cent.

But the number of hospitalisations for cardiovascular events in those given rosuvastatin was lower than in the placebo group.

It may be that rosuvastatin reduces acute atherothrombotic events in elderly heart failure patients, but has no effect on death rates in this group because this is primarily triggered by an electrical event related to ventricular dilatation and scarring, said Professor Hjalmarson.

Elisabeth Bjork, Astra Zeneca's global medical science director for rosuvastatin, said: 'The study included patients with advanced heart failure on optimal treatment who were not candidates for statin therapy.'

AHA scientific sessions 4-7 November 2007, Orlando, Florida

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Close up of hand holding sample tube with 'Omicron' handwritten on side

Government urged to 'free up' GP practices and expand steps to control Omicron

GPs have called for immediate action such as suspension of QOF to allow practices...

(Photo: Mike Kemp/Getty Images)

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

External wall of GP surgery with wording 'medical centre'

‘Utterly toxic’: GPs speak out over abuse and physical attacks on practice teams

GPs have condemned a rise in verbal and physical attacks on practice staff - warning...

Artist's image of a spiked virus

Javid warns of 'substantial risk' from new COVID-19 variant

The highly mutated COVID-19 variant B.1.1.529 'may pose a significant risk to public...

Desk with lettering 'LMC conference'

LMCs reject 'outdated' GMS contract and demand move to item of service payments

LMCs have voted to scrap the 'outdated and inadequate' GMS contract and to replace...

GPs at an LMC conference waving green voting cards in the air

LMCs demand ringfence on enhanced services cash and clear GP representation in ICSs

LMCs have called for a ringfence on enhanced services funding, along with a guarantee...